Medical Condition

neuroblastoma

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 2, Phase 3, Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for neuroblastoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — neuroblastoma Clinical Trials

How many clinical trials are currently recruiting for neuroblastoma?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for neuroblastoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for neuroblastoma?

neuroblastoma research spans Phase 1 (2 trials), Phase 2 (5 trials), Phase 3 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a neuroblastoma clinical trial?

Eligibility criteria for neuroblastoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

Memorial Sloan Kettering Cancer Center 2 trials

National Cancer Institute (NCI) 2 trials

Cancer Research UK 1 trial

Nationwide Children's Hospital 1 trial

St. Jude Children's Research Hospital 1 trial

Recruiting Clinical Trials

NCT05770037 Phase 2, Phase 3

Recruiting

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Nationwide Children's Hospital

View Trial →

NCT03050268

Recruiting

Familial Investigations of Childhood Cancer Predisposition

St. Jude Children's Research H...

View Trial →

NCT06057948 Phase 2

Recruiting

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cance...

View Trial →

NCT02508038 Phase 1

Recruiting

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

University of Wisconsin, Madis...

View Trial →

NCT02605421 Phase 2

Recruiting

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

Masonic Cancer Center, Univers...

View Trial →

NCT01109394

Recruiting

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

National Cancer Institute (NCI...

View Trial →

NCT06172296 Phase 3

Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Enrollment

478 pts

Location

United States, Austr...

Sponsor

National Cancer Institute (NCI...

View Trial →

NCT04936529 Phase 2

Recruiting

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cance...

View Trial →

NCT04706910 Phase 3

Recruiting

18F-DOPA II - PET Imaging Optimization

University of Alberta

View Trial →

NCT06852807

Recruiting

18F-mFBG PET Imaging in the Evaluation of Neuroblastoma

First Affiliated Hospital of Z...

View Trial →

NCT06500819 Phase 1

Recruiting

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

Related Conditions

sarcoma (3) hodgkin lymphoma (2) non hodgkin lymphoma (2) retinoblastoma (2) rhabdomyosarcoma (2) osteosarcoma (2) haematological malignancy (1) malignant neoplasm (1) lymphoproliferative disorders (1) neoplasms by histologic type (1) neoplasms by site (1) cancer (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology